Published in Mol Cell Biol on February 12, 2010
Functional shifts in insect microRNA evolution. Genome Biol Evol (2010) 2.94
MicroRNAs: Processing, Maturation, Target Recognition and Regulatory Functions. Mol Cell Pharmacol (2011) 2.25
Direct and indirect involvement of microRNA-499 in clinical and experimental cardiomyopathy. Circ Res (2012) 1.79
Mechanical Stretch Inhibits MicroRNA499 via p53 to Regulate Calcineurin-A Expression in Rat Cardiomyocytes. PLoS One (2016) 1.38
MicroRNAs in skeletal muscle: their role and regulation in development, disease and function. J Physiol (2010) 1.33
Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. J Clin Invest (2013) 1.29
A human 3' miR-499 mutation alters cardiac mRNA targeting and function. Circ Res (2012) 1.29
Elevated miR-499 levels blunt the cardiac stress response. PLoS One (2011) 1.28
Posttranscriptional mechanisms involving microRNA-27a and b contribute to fast-specific and glucocorticoid-mediated myostatin expression in skeletal muscle. Am J Physiol Cell Physiol (2010) 1.21
MicroRNAs in cardiac disease. Transl Res (2011) 1.13
miR-499 protects cardiomyocytes from H 2O 2-induced apoptosis via its effects on Pdcd4 and Pacs2. RNA Biol (2014) 1.06
Genome-wide mapping of Sox6 binding sites in skeletal muscle reveals both direct and indirect regulation of muscle terminal differentiation by Sox6. BMC Dev Biol (2011) 1.03
Early de novo DNA methylation and prolonged demethylation in the muscle lineage. Epigenetics (2013) 1.00
DNA methylation and differentiation: silencing, upregulation and modulation of gene expression. Epigenomics (2013) 0.97
MiR-499 regulates cell proliferation and apoptosis during late-stage cardiac differentiation via Sox6 and cyclin D1. PLoS One (2013) 0.95
Role of microRNAs in skeletal muscle hypertrophy. Front Physiol (2014) 0.95
Sox6, jack of all trades: a versatile regulatory protein in vertebrate development. Dev Dyn (2011) 0.94
MicroRNAs as biomarkers for myocardial infarction. Curr Atheroscler Rep (2012) 0.94
Evolution of the myosin heavy chain gene MYH14 and its intronic microRNA miR-499: muscle-specific miR-499 expression persists in the absence of the ancestral host gene. BMC Evol Biol (2013) 0.92
Negative auto-regulation of myostatin expression is mediated by Smad3 and microRNA-27. PLoS One (2014) 0.91
Increased expression of GDF-15 may mediate ICU-acquired weakness by down-regulating muscle microRNAs. Thorax (2014) 0.91
Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res (2012) 0.89
Heavy and light roles: myosin in the morphogenesis of the heart. Cell Mol Life Sci (2012) 0.89
MicroRNAs: redefining mechanisms in cardiac disease. J Cardiovasc Pharmacol (2010) 0.87
Sulforaphane causes a major epigenetic repression of myostatin in porcine satellite cells. Epigenetics (2012) 0.85
Helicase-like transcription factor (Hltf) regulates G2/M transition, Wt1/Gata4/Hif-1a cardiac transcription networks, and collagen biogenesis. PLoS One (2013) 0.84
The role of microRNAs in skeletal muscle health and disease. Front Biosci (Landmark Ed) (2015) 0.84
MicroRNA-499 expression distinctively correlates to target genes sox6 and rod1 profiles to resolve the skeletal muscle phenotype in Nile tilapia. PLoS One (2015) 0.82
Influence of microRNA-related polymorphisms on clinical outcomes in coronary artery disease. Am J Transl Res (2015) 0.81
The myriad essential roles of microRNAs in cardiovascular homeostasis and disease. Genes Dis (2014) 0.81
Evolution and genomic organization of muscle microRNAs in fish genomes. BMC Evol Biol (2014) 0.80
Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells. Skelet Muscle (2013) 0.80
Coupling of mitochondrial function and skeletal muscle fiber type by a miR-499/Fnip1/AMPK circuit. EMBO Mol Med (2016) 0.78
A genome-wide association study of congenital cardiovascular left-sided lesions shows association with a locus on chromosome 20. Hum Mol Genet (2016) 0.78
Egfl7 is differentially expressed in arteries and veins during retinal vascular development. PLoS One (2014) 0.77
Mechanisms of muscle gene regulation in the electric organ of Sternopygus macrurus. J Exp Biol (2013) 0.77
MicroRNA-208b progressively declines after spinal cord injury in humans and is inversely related to myostatin expression. Physiol Rep (2015) 0.76
Identification of Targets of CUG-BP, Elav-Like Family Member 1 (CELF1) Regulation in Embryonic Heart Muscle. PLoS One (2016) 0.76
Hsa-mir-499 rs3746444 T/C Polymorphism is Associated with Increased Risk of Coronary Artery Disease in a Chinese Population. Acta Cardiol Sin (2017) 0.75
Differential regulation of MCM7 and its intronic miRNA cluster miR-106b-25 during megakaryopoiesis induced polyploidy. RNA Biol (2014) 0.75
From Nutrient to MicroRNA: a Novel Insight into Cell Signaling Involved in Skeletal Muscle Development and Disease. Int J Biol Sci (2016) 0.75
Effect of fetal hypothyroidism on MyomiR network and its target gene expression profiles in heart of offspring rats. Mol Cell Biochem (2017) 0.75
Evolution and Distribution of Teleost myomiRNAs: Functionally Diversified myomiRs in Teleosts. Mar Biotechnol (NY) (2016) 0.75
Microarray profiling of microRNAs reveals frequent coexpression with neighboring miRNAs and host genes. RNA (2005) 14.14
Control of stress-dependent cardiac growth and gene expression by a microRNA. Science (2007) 12.08
MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell (2009) 8.14
Processing of intronic microRNAs. EMBO J (2007) 6.32
An E2F/miR-20a autoregulatory feedback loop. J Biol Chem (2006) 5.20
Multiple links between transcription and splicing. RNA (2004) 4.90
Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res (2007) 4.72
MicroRNA-208a is a regulator of cardiac hypertrophy and conduction in mice. J Clin Invest (2009) 4.39
MicroRNAs acting in a double-negative feedback loop to control a neuronal cell fate decision. Proc Natl Acad Sci U S A (2005) 3.69
A regulatory mechanism that detects premature nonsense codons in T-cell receptor transcripts in vivo is reversed by protein synthesis inhibitors in vitro. J Biol Chem (1995) 3.54
Unbalanced alternative splicing and its significance in cancer. Bioessays (2006) 3.17
A feedback regulatory loop involving microRNA-9 and nuclear receptor TLX in neural stem cell fate determination. Nat Struct Mol Biol (2009) 2.96
MicroRNAs flex their muscles. Trends Genet (2008) 2.94
Myosin gene mutation correlates with anatomical changes in the human lineage. Nature (2004) 2.69
Cloning and expression of new microRNAs from zebrafish. Nucleic Acids Res (2006) 2.58
Dose-dependent blockade to cardiomyocyte hypertrophy by histone deacetylase inhibitors. J Biol Chem (2003) 2.35
Cardiac and skeletal muscle adaptations to voluntary wheel running in the mouse. J Appl Physiol (1985) (2001) 2.24
Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle. Muscle Nerve (2005) 2.23
Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res (2000) 2.06
Sequence conservation, relative isoform frequencies, and nonsense-mediated decay in evolutionarily conserved alternative splicing. Proc Natl Acad Sci U S A (2005) 1.93
Small amounts of alpha-myosin heavy chain isoform expression significantly increase power output of rat cardiac myocyte fragments. Circ Res (2002) 1.91
Transcriptional and cell cycle-mediated regulation of myosin heavy chain gene expression during muscle cell differentiation. J Biol Chem (1983) 1.82
Factors controlling cardiac myosin-isoform shift during hypertrophy and heart failure. J Mol Cell Cardiol (2007) 1.81
Evidence of MyomiR network regulation of beta-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics (2009) 1.62
The Sry-related HMG box-containing gene Sox6 is expressed in the adult testis and developing nervous system of the mouse. Nucleic Acids Res (1995) 1.61
A critical role for myosin IIb in dendritic spine morphology and synaptic function. Neuron (2006) 1.60
Myostatin promotes the terminal differentiation of embryonic muscle progenitors. Genes Dev (2008) 1.52
Comparative sequence analysis of the complete human sarcomeric myosin heavy chain family: implications for functional diversity. J Mol Biol (1999) 1.52
Sox6 is required for normal fiber type differentiation of fetal skeletal muscle in mice. Dev Dyn (2007) 1.49
A systematic analysis of intronic sequences downstream of 5' splice sites reveals a widespread role for U-rich motifs and TIA1/TIAL1 proteins in alternative splicing regulation. Genome Res (2008) 1.44
Regulation of myosin heavy chain genes in the heart. Circulation (1993) 1.37
Rapid turnover of extracellular signal-regulated kinase 3 by the ubiquitin-proteasome pathway defines a novel paradigm of mitogen-activated protein kinase regulation during cellular differentiation. Mol Cell Biol (2003) 1.35
Slow and fast fiber isoform gene expression is systematically altered in skeletal muscle of the Sox6 mutant, p100H. Dev Dyn (2005) 1.25
Sox6 is a candidate gene for p100H myopathy, heart block, and sudden neonatal death. Proc Natl Acad Sci U S A (2000) 1.21
Structure-function analysis of the motor domain of myosin. Annu Rev Cell Dev Biol (1996) 1.14
Sox6 regulation of cardiac myocyte development. Nucleic Acids Res (2003) 1.11
Evolutionary implications of three novel members of the human sarcomeric myosin heavy chain gene family. Mol Biol Evol (2002) 1.10
Cardiomyocyte preparation, culture, and gene transfer. Methods Mol Biol (2007) 1.08
Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. Dev Biol (1992) 1.08
Intrinsic expression of host genes and intronic miRNAs in prostate carcinoma cells. Cancer Cell Int (2009) 1.04
Sp3 proteins negatively regulate beta myosin heavy chain gene expression during skeletal muscle inactivity. Mol Cell Biol (2004) 1.00
Molecular mechanism of osteochondroprogenitor fate determination during bone formation. Adv Exp Med Biol (2006) 0.98
Transcription factor Sp3 knockout mice display serious cardiac malformations. Mol Cell Biol (2007) 0.95
Suppression of Sox6 in P19 cells leads to failure of neuronal differentiation by retinoic acid and induces retinoic acid-dependent apoptosis. FEBS Lett (2004) 0.93
Identifying pattern-defined regulatory islands in mammalian genomes. Proc Natl Acad Sci U S A (2007) 0.84
Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation (2006) 4.69
Valvular myofibroblast activation by transforming growth factor-beta: implications for pathological extracellular matrix remodeling in heart valve disease. Circ Res (2004) 2.45
A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell (2012) 2.35
The TEL patch of telomere protein TPP1 mediates telomerase recruitment and processivity. Nature (2012) 2.33
Evidence that opioids may have toll-like receptor 4 and MD-2 effects. Brain Behav Immun (2009) 2.19
Genetic variability in forced and voluntary endurance exercise performance in seven inbred mouse strains. J Appl Physiol (1985) (2002) 2.15
Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res (2006) 2.09
Gene mutations and genomic rearrangements in the mouse as a result of transposon mobilization from chromosomal concatemers. PLoS Genet (2006) 1.84
Future research directions in idiopathic pulmonary fibrosis: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med (2002) 1.76
Controlling pathological pain by adenovirally driven spinal production of the anti-inflammatory cytokine, interleukin-10. Eur J Neurosci (2005) 1.73
Intrathecal interleukin-10 gene therapy attenuates paclitaxel-induced mechanical allodynia and proinflammatory cytokine expression in dorsal root ganglia in rats. Brain Behav Immun (2006) 1.67
Controlling neuropathic pain by adeno-associated virus driven production of the anti-inflammatory cytokine, interleukin-10. Mol Pain (2005) 1.66
Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain. Pain (2006) 1.66
The cell biology of disease: cellular mechanisms of cardiomyopathy. J Cell Biol (2011) 1.54
Hibernating squirrel muscle activates the endurance exercise pathway despite prolonged immobilization. Exp Neurol (2013) 1.52
Crosslinked hyaluronan scaffolds as a biologically active carrier for valvular interstitial cells. Biomaterials (2005) 1.51
Competencies: a cure for pre-med curriculum. Science (2011) 1.47
Designing scaffolds for valvular interstitial cells: cell adhesion and function on naturally derived materials. J Biomed Mater Res A (2004) 1.43
Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function. Proc Natl Acad Sci U S A (2013) 1.42
Redirecting valvular myofibroblasts into dormant fibroblasts through light-mediated reduction in substrate modulus. PLoS One (2012) 1.41
Fatty acids identified in the Burmese python promote beneficial cardiac growth. Science (2011) 1.30
Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Res (2010) 1.30
Soy diet worsens heart disease in mice. J Clin Invest (2006) 1.29
Loaded wheel running and muscle adaptation in the mouse. Am J Physiol Heart Circ Physiol (2005) 1.23
Hydrogels preserve native phenotypes of valvular fibroblasts through an elasticity-regulated PI3K/AKT pathway. Proc Natl Acad Sci U S A (2013) 1.20
Bioinformatics assessment of beta-myosin mutations reveals myosin's high sensitivity to mutations. Trends Cardiovasc Med (2008) 1.20
Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension. J Mol Cell Cardiol (2011) 1.19
Sex modifies exercise and cardiac adaptation in mice. Am J Physiol Heart Circ Physiol (2004) 1.18
Functional diversity among a family of human skeletal muscle myosin motors. Proc Natl Acad Sci U S A (2009) 1.18
Intrathecal polymer-based interleukin-10 gene delivery for neuropathic pain. Neuron Glia Biol (2006) 1.18
Statins block calcific nodule formation of valvular interstitial cells by inhibiting alpha-smooth muscle actin expression. Arterioscler Thromb Vasc Biol (2009) 1.16
Sex-based cardiac physiology. Annu Rev Physiol (2009) 1.13
Pregnancy as a cardiac stress model. Cardiovasc Res (2014) 1.11
MyoD, Myf5, and the calcineurin pathway activate the developmental myosin heavy chain genes. Dev Biol (2006) 1.09
Cardiomyocyte preparation, culture, and gene transfer. Methods Mol Biol (2007) 1.08
The effects of biological sex and diet on the development of heart failure. Circulation (2007) 1.07
Intracellular calcium and myosin isoform transitions. Calcineurin and calcium-calmodulin kinase pathways regulate preferential activation of the IIa myosin heavy chain promoter. J Biol Chem (2002) 1.07
Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.06
Restoration of CREB function is linked to completion and stabilization of adaptive cardiac hypertrophy in response to exercise. Am J Physiol Heart Circ Physiol (2007) 1.06
Integrin-linked kinase production prevents anoikis in human mesenchymal stem cells. J Biomed Mater Res A (2007) 1.05
Skeletal myosin heavy chain function in cultured lung myofibroblasts. J Cell Biol (2003) 1.05
Erratum to: Identification of functional differences between recombinant human α and β cardiac myosin motors. Cell Mol Life Sci (2012) 1.01
Myocyte enhancer factor-2 and serum response factor binding elements regulate fast Myosin heavy chain transcription in vivo. J Biol Chem (2005) 1.01
Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T. Circulation (2004) 0.99
Morphological and functional alterations in ventricular myocytes from male transgenic mice with hypertrophic cardiomyopathy. Circ Res (2003) 0.98
Mutations in the beta-myosin rod cause myosin storage myopathy via multiple mechanisms. Proc Natl Acad Sci U S A (2009) 0.98
Akt and MAPK signaling mediate pregnancy-induced cardiac adaptation. J Appl Physiol (1985) (2012) 0.97
Expression of cardiac troponin T with COOH-terminal truncation accelerates cross-bridge interaction kinetics in mouse myocardium. Am J Physiol Heart Circ Physiol (2004) 0.97
Whole transcriptome analysis of the fasting and fed Burmese python heart: insights into extreme physiological cardiac adaptation. Physiol Genomics (2010) 0.95
Mutations at the same amino acid in myosin that cause either skeletal or cardiac myopathy have distinct molecular phenotypes. J Mol Cell Cardiol (2009) 0.94
Activation of serum/glucocorticoid-induced kinase 1 (SGK1) is important to maintain skeletal muscle homeostasis and prevent atrophy. EMBO Mol Med (2012) 0.94
IIb or not IIb? Regulation of myosin heavy chain gene expression in mice and men. Skelet Muscle (2011) 0.93
Loss of desmin leads to impaired voluntary wheel running and treadmill exercise performance. J Appl Physiol (1985) (2003) 0.93
Yin Yang 1 represses alpha-myosin heavy chain gene expression in pathologic cardiac hypertrophy. Biochem Biophys Res Commun (2005) 0.92
A randomized library approach to identifying functional lox site domains for the Cre recombinase. Nucleic Acids Res (2007) 0.90
The role of Akt/GSK-3beta signaling in familial hypertrophic cardiomyopathy. J Mol Cell Cardiol (2009) 0.90
Increased thermoregulation in cold-exposed transgenic mice overexpressing lipoprotein lipase in skeletal muscle: an avian phenotype? J Lipid Res (2008) 0.90
Fighting fat with muscle: bulking up to slim down. Cell Metab (2008) 0.90
Effects of pathogenic proline mutations on myosin assembly. J Mol Biol (2011) 0.90
Metabolic crosstalk between the heart and liver impacts familial hypertrophic cardiomyopathy. EMBO Mol Med (2014) 0.90
Myosin heavy chain is not selectively decreased in murine cancer cachexia. Int J Cancer (2011) 0.89
Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res (2012) 0.89
Blocking cardiac growth in hypertrophic cardiomyopathy induces cardiac dysfunction and decreased survival only in males. Am J Physiol Heart Circ Physiol (2006) 0.89
Calcineurin activity is required for cardiac remodelling in pregnancy. Cardiovasc Res (2013) 0.88
Interferon-γ causes cardiac myocyte atrophy via selective degradation of myosin heavy chain in a model of chronic myocarditis. Am J Pathol (2012) 0.88
Intrathecal injection of naked plasmid DNA provides long-term expression of secreted proteins. Mol Ther (2008) 0.88
Alterations in mitochondrial function in a mouse model of hypertrophic cardiomyopathy. Am J Physiol Heart Circ Physiol (2002) 0.88
Remodeling the cardiac transcriptional landscape with diet. Physiol Genomics (2011) 0.88
Characterization of cell subpopulations expressing progenitor cell markers in porcine cardiac valves. PLoS One (2013) 0.86
Diversity in transcriptional start site selection and alternative splicing affects the 5'-UTR of mouse striated muscle myosin transcripts. J Muscle Res Cell Motil (2006) 0.86
Serum deprivation improves seeding and repopulation of acellular matrices with valvular interstitial cells. J Biomed Mater Res A (2005) 0.85
Rational promoter selection for gene transfer into cardiac cells. J Mol Cell Cardiol (2003) 0.84
Cell type specific targeted intracellular delivery into muscle of a monoclonal antibody that binds myosin IIb. Mol Immunol (2003) 0.83
Estrogenic compounds are not always cardioprotective and can be lethal in males with genetic heart disease. Endocrinology (2012) 0.83
Distinct cardiac transcriptional profiles defining pregnancy and exercise. PLoS One (2012) 0.82
The superfast human extraocular myosin is kinetically distinct from the fast skeletal IIa, IIb, and IId isoforms. J Biol Chem (2013) 0.82
Acute effects of desmin mutations on cytoskeletal and cellular integrity in cardiac myocytes. Cell Motil Cytoskeleton (2003) 0.82
Interplay between exonic splicing enhancers, mRNA processing, and mRNA surveillance in the dystrophic Mdx mouse. PLoS One (2007) 0.81
Estimate of the abundance of cardiomyopathic mutations in the β-myosin gene. Int J Cardiol (2009) 0.81
Molecular and genetic approaches to studying exercise performance and adaptation. Exerc Sport Sci Rev (2002) 0.79
Regulation of physiological and metabolic function of muscle by female sex steroids. Med Sci Sports Exerc (2012) 0.79
A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype. Biochem Biophys Res Commun (2009) 0.79
Impaired skeletal muscle regeneration in the absence of fibrosis during hibernation in 13-lined ground squirrels. PLoS One (2012) 0.78
Immunogenicity of intrathecal plasmid gene delivery: cytokine release and effects on transgene expression. J Gene Med (2009) 0.78
Partnering up for cardiac hypertrophy. Circ Res (2006) 0.77
GFP fails to inhibit actin-myosin interactions in vitro. Nat Methods (2008) 0.77
Measuring microRNA reporter activity in skeletal muscle using hydrodynamic limb vein injection of plasmid DNA combined with in vivo imaging. Skelet Muscle (2013) 0.76
Estrogens mediate cardiac hypertrophy in a stimulus-dependent manner. Endocrinology (2012) 0.76
Myosin filament assembly requires a cluster of four positive residues located in the rod domain. FEBS Lett (2012) 0.76
The role of MEKK1 in hypertrophic cardiomyopathy. Int Heart J (2010) 0.75
Frank Ruddle (1929-2013). Am J Hum Genet (2013) 0.75
Rescuing cardiac malfunction: the roles of the chaperone-like small heat shock proteins. Circ Res (2008) 0.75
Mechanisms of the pathogenesis of troponin T-based familial hypertrophic cardiomyopathy. Trends Cardiovasc Med (2003) 0.75
Task Force on Strategic Research Direction: Basic Science Subgroup key science topics report. Circulation (2002) 0.75
Suppressor tRNAs: protocols and applications for cardiac gene transfer. Methods Mol Biol (2003) 0.75
Direct gene transfer into mouse heart. Methods Enzymol (2002) 0.75